Vessel formation is induced prior to the appearance of cartilage in BMP-2-mediated heterotopic ossification

Journal of Bone and Mineral Research

Volumn 25, Issue 5, 2010, Pages 1147-1156

  Dilling, Christine Fouletier ^a   Wada, Aya M ^b   Lazard, Zawaunyka W ^a   Salisbury, Elizabeth A ^a   Gannon, Francis H ^b   Vadakkan, Tegy J ^b   Gao, Liang ^b   Hirschi, Karen ^a,b   Dickinson, Mary E ^b   Davis, Alan R ^a,b   Olmsted Davis, Elizabeth A ^a,b  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bone morphogentic protein type 2; Heterotopic ossification; Vessel formation

Indexed keywords

BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN 2; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; YELLOW FLUORESCENT PROTEIN;

ADENOVIRUS; ADIPOCYTE; ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARTILAGE; CELL DIVISION; CHONDROGENESIS; CONTROLLED STUDY; ENDOTHELIUM CELL; ENGRAFTMENT; HETEROTOPIC OSSIFICATION; MICROENVIRONMENT; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STEM CELL; VASCULARIZATION;

ADIPOCYTES, BROWN; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CARTILAGE; KI-67 ANTIGEN; MICE; OSSIFICATION, HETEROTOPIC; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VON WILLEBRAND FACTOR;

EID: 77953499330     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.091031     Document Type: Article

References (35)

1. Fraser ST, Hadjantonakis AK, Sahr KE, et al. Using a histone yellow fluorescent protein fusion for tagging and tracking endothelial cells in ES cells and mice. Genesis. 2005;42:162-171.
2. Shafer J, Davis AR, Gannon FH, et al. Oxygen tension directs chondrogenic differentiation of myelo-monocytic progenitors during endochondral bone formation. Tissue Eng. 2007;13:2011-2019.
3. Colnot C, Lu C, Hu D, Helms JA. Distinguishing the contributions of the perichondrium, cartilage, and vascular endothelium to skeletal development. Dev Biol. 2004;269:55-69.
4. Maes C, Stockmans I, Moermans K, et al. Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J Clin Invest. 2004;113:188-199.
5. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med. 1999;5:623-628.
6. Li J, Zhang YP, Kirsner RS. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc Res Tech. 2003;60:107-114. (Pubitemid 36055239)
7. Fouletier-Dilling CM, Gannon FH, Olmsted-Davis EA, et al. Efficient and rapid osteoinduction in an immune-competent host. Hum Gene Ther. 2007;18:733-745.
8. Olmsted-Davis E, Gannon FH, Ozen M, et al. Hypoxic adipocytes pattern early heterotopic bone formation. Am J Pathol. 2007;170:620-632. (Pubitemid 47339399)
9. Shen M, Yoshida E, Yan W, et al. Basic helix-loop-helix protein DEC1 promotes chondrocyte differentiation at the early and terminal stages. J Biol Chem. 2002;277:50112-50120. (Pubitemid 36014464)
10. Hadjantonakis AK, Dickinson ME, Fraser SE, Papaioannou VE. Technicolour transgenics: imaging tools for functional genomics in the mouse. Nat Rev Genet. 2003;4:613-625.
11. Olmsted EA, Blum JS, Rill D, et al. Adenovirus-mediated BMP2 expression in human bone marrow stromal cells. J Cell Biochem. 2001;82:11-21. (Pubitemid 32500137)
12. Fouletier-Dilling CM, Bosch P, Davis AR, et al. Novel compound enables high-level adenovirus transduction in the absence of an adenovirus-specific receptor. Hum Gene Ther. 2005;16:1287-1297. (Pubitemid 41611656)
13. Olmsted-Davis EA, Gugala Z, Gannon FH, et al. Use of a chimeric adenovirus vector enhances BMP2 production and bone formation. Hum Gene Ther. 2002;13:1337-1347. (Pubitemid 35034513)
14. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983;31:13-20. (Pubitemid 13179545)
15. Sato Y, Kanno S, Oda N, et al. Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction. Ann NY Acad Sci. 2000;902: 201-5; discussion 205-207. (Pubitemid 30389124)
16. Reddi AH. Bone and cartilage differentiation. Curr Opin Genet Dev. 1994;4:737-744.
17. Trelles RD, Leon JR, Kawakami Y, Simoes S, Belmonte JC. Expression of the chick vascular endothelial growth factor D gene during limb development. Mech Dev. 2002;116:239-242. (Pubitemid 34786435)
18. Reddi AH. Regulation of cartilage and bone differentiation by bone morphogenetic proteins. Curr Opin Cell Biol. 1992;4:850-855.
19. Zelzer E, McLean W, Ng YS, et al. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development. 2002;129:1893-1904.
20. Li X, Cao X. BMP signaling and skeletogenesis. Ann N Y Acad Sci. 2006;1068:26-40.
21. Hogan BL. Bone morphogenetic proteins in development. Curr Opin Genet Dev. 1996;6:432-438.
22. Shafer J, Gannon DA, Fouletier-Dilling FH, et al. Oxygen tension directs chondrogenic differentiation of myelo-monocytic progenitors during endochondral bone formation. Tissue Eng. 2007;13:2011-2019.
23. Rissanen TT, Markkanen JE, Gruchala M, et al. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res. 2003;92:1098-1106.
24. Moser M, Binder O, Wu Y, et al. BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation. Mol Cell Biol. 2003;23:5664-5679.
25. Mishina Y, Suzuki A, Gilbert DJ, et al. Genomic organization and chromosomal location of the mouse type I BMP-2/4 receptor. Biochem Biophys Res Commun. 1995;206:310-317.
26. Winnier G, Blessing M, Labosky PA, Hogan BL. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 1995;9:2105-2116.
27. Kelly MA, Hirschi KK. Signaling Hierarchy Regulating Human Endothelial Cell Development. Arterioscler Thromb Vasc Biol. 2009.
28. Zhao Y, Glesne D, Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A. 2003;100:2426-2431.
29. Ruster B, Gottig S, Ludwig RJ, et al. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood. 2006;108:3938-3944.
30. Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y. Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Biochem Biophys Res Commun. 2007;354:453-458.
31. Pufe T, Petersen WJ, Miosge N, et al. Endostatin/collagen XVIII-an inhibitor of angiogenesis-is expressed in cartilage and fibrocartilage. Matrix Biol. 2004;23:267-276.
32. Oshima Y, Sato K, Tashiro F, et al. Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I. J Cell Sci. 2004;117:2731-2744.
33. Hayami T, Funaki H, Yaoeda K, et al. Expression of the cartilage derived anti-angiogenic factor chondromodulin-I decreases in the early stage of experimental osteoarthritis. J Rheumatol. 2003;30:2207-2217.
34. Kaplan FS, Glaser DL, Shore EM, et al. Hematopoietic stem-cell contribution to ectopic skeletogenesis. J Bone Joint Surg Am. 2007;89:347-357.
35. Shukunami C, Iyama K, Inoue H, Hiraki Y. Spatiotemporal pattern of the mouse chondromodulin-I gene expression and its regulatory role in vascular invasion into cartilage during endochondral bone formation. Int J Dev Biol. 1999;43:39-49.